UAE market indices at close

Friday, 6 November 2026 ·

Dubai Financial Market Index

6,025.55

-17.10 / -0.28%

Exchange summary (trading totals unavailable)

Trading volume
—
Traded value (AED)
—
Number of trades
—

FTSE ADX General Index (FADGI)

9,392.60

-127.22 / -1.34%

Exchange summary (trading totals unavailable)

Trading volume
—
Traded value (AED)
—
Number of trades
—

Dated session snapshot, not a live feed. Whole-exchange trading totals were not supplied for this session.

GoFinsa

Welcome to GoFinsa!

Pure Health Holding P.J.S.C.

PUREHEALTH
2.49 AED
Change: -0.4%
Latest available price · 2026-11-06

PUREHEALTH — price data

Supplied closing session:

Session close, as supplied
2.49 AED
6 November session change
-0.4%
Session volume (shares)
1.51M (rounded)
Session relative volume
0.75

Retained financial metrics — not refreshed by this close

Financial reference date: 2026-10-19

Reference market capitalization
2.922e+10 AED
Reference trailing P/E
13.41
Reference trailing EPS
0.19 AED
Reference dividend yield
2.06%
Retained analyst sentiment
غير متوفر

Dated, user-supplied session data, not live prices or independently verified official closes. K/M volumes retain source rounding. Financial metrics and GFSI ratings have not been recalculated.

Pure Health Holding P.J.S.C. stock (PUREHEALTH) price and technical analysis

GoFinsa tracks Pure Health Holding P.J.S.C. under symbol PUREHEALTH, with the latest available price at 2.49 AED. This page includes multi-timeframe charts, technical analysis and related market news.

The session change is -0.4%.

Market data source: 2026-11-06 session close, as supplied · Latest available update: 2026-11-06 · Delayed market data

PureHealth Holding (PUREHEALTH) Stock Analysis: 2026 Results, Price, Dividends and Risks

PureHealth Holding is listed under ticker PUREHEALTH on the Abu Dhabi Securities Exchange. It operates in healthcare services, insurance and medical operations. This guide focuses on the company, operating performance, capital structure and disclosed risks rather than forecasting a trading signal or promoting a fixed price target. Equity ownership should not be confused with leveraged contracts for difference. Hospital operations, insurance cover and cross-border healthcare have distinct

Company overview and business model

PureHealth Holding is listed under ticker PUREHEALTH on the Abu Dhabi Securities Exchange. It operates in healthcare services, insurance and medical operations. This guide focuses on the company, operating performance, capital structure and disclosed risks rather than forecasting a trading signal or promoting a fixed price target. Equity ownership should not be confused with leveraged contracts for difference.

Hospital operations, insurance cover and cross-border healthcare have distinct margins and underwriting or reimbursement risks.

Share price snapshot — 14 October 2026

User-provided reference quote: AED 2.65; session change: −0.75%; indicative market capitalisation: AED 29.67 billion; displayed trailing P/E: 13.77; displayed trailing EPS: AED 0.19; dividend-related screen field: 2.02% unverified snapshot indication. This is a dated reference snapshot, not a real-time feed or an independently confirmed official exchange closing price.

The snapshot shows a one-year share-price change of −4.68%. Historical price return, reinvested dividend total return and corporate-action-adjusted return are different metrics. P/E and EPS need reconciliation to a named financial reporting period before they are used in a valuation model.

Official reporting and results

Company disclosure: H1 2026 revenue reached approximately AED 14.9 billion, up 9.4% year on year.

Company disclosure: H1 EBITDA was AED 2.9 billion, up 23.9%, and net profit was AED 1.2 billion, up 20.1% year on year.

Figures from half-year releases should not be presented as full-year audited outcomes. Note whether a disclosed number is attributable to parent shareholders, an EBITDA measure or a gross consolidated result, and check the reporting currency.

Revenue generation and earnings drivers

Acquisitions can increase consolidated revenue without matching organic growth; consolidation effects matter.

The key analytical task for PUREHEALTH is to map the economic source of revenue to unit volumes, prices, cost structure and capital intensity. Recurring contracts differ from one-off gains, and accounting consolidation can make reported growth look different from same-business organic growth. Gross revenue does not automatically become shareholder cash flow.

Earnings quality, cash flow and valuation

Profit is only one step in analysing PureHealth Holding. Operating cash flow, working capital, receivables, debt service and maintenance capital expenditure are important parts of a sustainable earnings assessment. Low reported valuation multiples can reflect risks rather than an undervalued stock; higher multiples can reflect expected growth that may fail to materialise.

Medical tariffs, claims settlement and regulatory changes can influence cash conversion and profitability.

Dividends: disclosures versus screen-derived yield

The snapshot contains the following dividend-related field: 2.02% unverified snapshot indication. It is not by itself a verified dividend resolution. The amount per share, entitlement date, payout date and whether payment was approved require an issuer or exchange disclosure.

Even a history of cash distributions cannot guarantee the next payment. The source, financial period and currency of each declared dividend matter more than an estimated yield shown without a declaration reference.

Peer comparison and sector metrics

A comparison of PUREHEALTH with peers in healthcare services, insurance and medical operations should focus on business-model comparability, leverage, margins, asset quality and cyclicality. A generic ranking based on P/E alone ignores the reasons peers earn different returns on capital. Sector reporting policies, acquisition effects and the timing of project completion may require adjustments.

Analysts should align reporting periods and definitions; EBITDA, net income and distributable cash flow are not interchangeable. Never infer the viability of a future dividend simply from a trailing yield number.

Core investment and operating risks

PureHealth Holding faces risks linked to its customers, financing, operating costs and regulatory or market conditions. Inflation, higher borrowing costs, competition, exchange-rate movements, delayed collections or unforeseen legal liabilities can impair returns. Price performance over recent months is not a guarantee of a similar forward return.

Corporate actions such as equity issuance, mergers and asset acquisitions can change both reported financial ratios and shareholder economic interests. They should be reviewed through official disclosures rather than informal social-media projections.

How to assess future filings

For the next PUREHEALTH report, identify the exact reporting window, compare the same period last year, and explain unusual movements in sales, margins, provisions and cash generation. Read the notes on contingencies, related-party balances, debt maturities and management outlook. Any announcement after a reporting date belongs to the subsequent-events discussion.

Keep a dated chronology of declared dividends and corporate events. Earnings-calendar estimates from a third-party quote page should not be described as confirmed company release dates.

Research checklist before investing

Before making an investment decision about PureHealth Holding, evaluate management execution, operating resilience, financing, distributions and the valuation implicit in the current quote. Stress-test growth and margins under different conditions; a single earnings multiple or analyst rating is not enough to establish fair value.

The material is general research, not individually tailored investment advice. Any projections require explicit assumptions and are subject to uncertainty.

Real shares versus global trading instruments

Ownership of a real PUREHEALTH share requires an intermediary providing access to ADX. No claim is made here that XTB lists this specific UAE stock. XTB is mentioned as a promotional option for learning about eligible global-market tools and demo functionality, subject to country, account and instrument availability.

CFDs and other derivatives differ from share ownership and can involve leverage, overnight financing and rapid losses. Check the contractual counterparty and all costs before funding an account.

Frequently asked questions

What was the reference share price on 14 October 2026? AED 2.65, based on a supplied market snapshot, not a live quote.

Does PUREHEALTH offer guaranteed dividends? No. Official declarations, record dates and payout conditions must be confirmed.

Can I buy PUREHEALTH directly through XTB? Availability has not been verified here; consult XTB instrument specifications for your entity.

Which numbers matter most? Read earnings, cash conversion, balance sheet, growth and sector-specific risks together.

Official sources and related research

The source URLs below identify company investor relations pages or official disclosures used for the company-specific facts. Verify the exact period before reusing any figure.

[Official source 1](https://purehealth.ae/investor-relations/)

[Official source 2](https://purehealth.ae/financial-information/)

[GoFinsa stock page](/en/markets/ae-xads-purehealth) and [UAE markets research](/en/search?q=UAE%20stocks).

Risk and disclosure: affiliate links may generate compensation. Verify account eligibility. Shares and derivatives can incur losses.

المصادر والمراجع

    أسئلة شائعة عن الشركة

    What was the reference share price on 14 October 2026?

    AED 2.65, based on a supplied market snapshot, not a live quote.

    Does PUREHEALTH offer guaranteed dividends?

    No. Official declarations, record dates and payout conditions must be confirmed.

    Can I buy PUREHEALTH directly through XTB?

    Availability has not been verified here; consult XTB instrument specifications for your entity.

    Which numbers matter most?

    Read earnings, cash conversion, balance sheet, growth and sector-specific risks together.

    Frequently asked questions about Pure Health Holding P.J.S.C. (PUREHEALTH)

    What is the price of Pure Health Holding P.J.S.C. (PUREHEALTH)?

    The latest price available in GoFinsa data is 2.49 AED. Price status may be live or delayed depending on the market and data provider.

    What does the technical analysis for Pure Health Holding P.J.S.C. (PUREHEALTH) show?

    There is currently insufficient data to produce technical analysis for this instrument.

    What is the GoFinsa.com General Index for Pure Health Holding P.J.S.C.?

    The GoFinsa.com General Index is currently unavailable for this instrument.